BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7982237)

  • 1. Oncogene activation: an informative marker for the human papillomavirus-lesions severity.
    Bernard C; Mougin C; Laurent R; Lab M
    Cancer Detect Prev; 1994; 18(4):273-82. PubMed ID: 7982237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human papillomaviruses and cellular oncogenes (c-myc, c-Ha-ras) in cutaneous and mucosal lesions in transplantation recipients].
    Pélisson I; Soler C; Chignol MC; Euvrard S; Chardonnet Y
    Bull Cancer; 1992; 79(5):471-82. PubMed ID: 1330099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human cytomegalovirus in female and male anogenital lesions with papillomavirus-associated dysplastic changes.
    Mougin C; Bernard C; Schaal JP; Laurent R; Carbillet JP; Lab M
    Cancer Detect Prev; 1995; 19(4):316-24. PubMed ID: 7553673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anogenital papillomavirus lesions in humans with or without HIV infection. Comparison of colposcopic, histopathological and virological results].
    Van Landuyt H; Mougin C; Drobacheff C; Bernard C; Merle C; Lab M; Laurent R
    Ann Dermatol Venereol; 1993; 120(4):281-6. PubMed ID: 8239375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
    Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
    Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 expression in relation to human papillomavirus in anogenital lesions.
    Samama B; Lipsker D; Boehm N
    Hum Pathol; 2006 May; 37(5):513-9. PubMed ID: 16647947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region].
    Hadzić B; Djurdjević S; Hadzić M; Jerant-Patić V
    Med Pregl; 1998; 51(5-6):265-70. PubMed ID: 9720356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening methods for high-grade dysplasia in patients with anal condyloma.
    Papaconstantinou HT; Lee AJ; Simmang CL; Ashfaq R; Gokaslan ST; Sokol S; Huber PJ; Gregorcyk SG
    J Surg Res; 2005 Jul; 127(1):8-13. PubMed ID: 15964301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital viral infections. Studies on human papillomavirus and Epstein-Barr virus.
    Voog E
    Acta Derm Venereol Suppl (Stockh); 1996; 198():1-55. PubMed ID: 9111847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of cyclin A mRNA in intra-epithelial lesions of the anogenital tract induced by papillomavirus].
    Didier JM; Mougin C; Paterlini P; Kantelip JP; Brechot C; Lab M
    C R Seances Soc Biol Fil; 1995; 189(1):111-26. PubMed ID: 7648362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women.
    Chabaud M; Le Cann P; Mayelo V; Leboulleux D; Diallo AS; Enogat N; Afoutou JM; Anthonioz P; Coll-Seck AM; Coursaget P
    J Med Virol; 1996 Aug; 49(4):259-63. PubMed ID: 8877756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type in anal epithelial lesions is influenced by human immunodeficiency virus.
    Unger ER; Vernon SD; Lee DR; Miller DL; Sharma S; Clancy KA; Hart CE; Reeves WC
    Arch Pathol Lab Med; 1997 Aug; 121(8):820-4. PubMed ID: 9278609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
    Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.
    Piketty C; Darragh TM; Heard I; Da Costa M; Bruneval P; Kazatchkine MD; Palefsky JM
    Sex Transm Dis; 2004 Feb; 31(2):96-9. PubMed ID: 14743072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.